Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.67 |
| ▸ | MEN1 | O00255 | 5/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.67 |
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | BRD4 | O60885 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | TOP2A | P11388 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amifloxacin SCHEMBL28198749 | 1.00 | ALDH1A1 (0.70) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| Amifloxacin SCHEMBL29371634 | 1.00 | ALDH1A1 (0.70) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| Amifloxacin SCHEMBL9788088 | 0.99 | ALDH1A1 (0.69) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| Amifloxacin SCHEMBL29682399 | 0.96 | KDM4E (0.74) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| Amifloxacin SCHEMBL193463 | 0.96 | KDM4E (0.74) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| SCHEMBL16518624 | 0.92 | ALDH1A1 (0.59) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| SCHEMBL10923393 | 0.91 | ALDH1A1 (0.57) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| SCHEMBL2859863 | 0.90 | ALDH1A1 (0.57) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| SCHEMBL10919811 | 0.90 | MEN1 (0.57) | ALDH1A1DRD3KDM4EMEN1KMT2A | |
| SCHEMBL10918825 | 0.89 | KDM4E (0.70) | ALDH1A1DRD3KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4750 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624057-B2 | Bisphosphonate quinolone conjugates and uses thereof | BIOVINC, LLC (US) | 2026-05-12 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4571306-A1 | STABILIZING OXYGEN IN A COMPOSITION | Instrumentation Laboratory Company (US) | 2025-06-18 | — | — | EP | claimed |
| CN-120142412-A | Stabilizing oxygen in a composition | 仪器实验室公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250189479-A1 | STABILIZING OXYGEN IN A COMPOSITION | INSTRUMENTATION LABORATORY COMPANY | 2025-06-12 | — | — | US | claimed |
| US-20240408070-A1 | COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM | BORODY THOMAS J (AU) | 2024-12-12 | — | — | US | claimed |
| EP-4472649-A1 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON ADMINISTRATION, AND USES | AGS Therapeutics SAS (FR) | 2024-12-11 | — | — | EP | claimed |
| CN-118340907-A | Polymer conjugates comprising bioactive agents | 波利艾克蒂瓦有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20240182504-A1 | BISPHOSPHONATE QUINOLONE CONJUGATES AND USES THEREOF | BIOVINC LLC (US) | 2024-06-06 | — | — | US | claimed |
| US-20230404983-A1 | COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER | CENTRE FOR DIGESTIVE DISEASES (AU) | 2023-12-21 | — | — | US | claimed |
| US-5223246-A | Powdered mixture of antibacterial oxo-carboxylic acids having fused nitrogen rings, carbonates, water soluble binders, for treatment of drinking water for livestock | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-29 | — | — | US | claimed |
| EP-0443381-A1 | Effervescent composition, its production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-08-28 | — | — | EP | claimed |
| WO-1991009616-A1 | QUINOLONE ANTIBIOTICS ENCAPSULATED IN LIPID VESICLES | YALE UNIVERSITY (US) | 1991-07-11 | — | — | WO | claimed |
| US-4895803-A | QUINOLINE-OR NAPHTHAPYRIDINE/1,8-/ DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1990-01-23 | — | — | US | claimed |
| US-4853225-A | Process for implanting a medicament depot | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-08-01 | — | — | US | claimed |
| US-4844902-A | Topically applicable formulations of gyrase inhibitors in combination with corticosteroids | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | claimed |
| EP-0280915-A2 | Preparations for topical use of gyrase inhibitors in combination with corticosteroids | BAYER AG (DE) | 1988-09-07 | — | — | EP | claimed |
| EP-0090424-B1 | NEW QUINOLONE COMPOUNDS AND PREPARATION THEREOF | STERLING DRUG INC. (US) | 1986-05-28 | — | — | EP | claimed |
| US-4499091-A | 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents | STERLING DRUG INC. (US) | 1985-02-12 | — | — | US | claimed |
| EP-0090424-A1 | New quinolone compounds and preparation thereof | STERLING DRUG INC. (US) | 1983-10-05 | — | — | EP | claimed |